He Liang Fu
Chairman bei JIANGSU AIDEA PHARMACEUTICAL CO., LTD.
Vermögen: 3 Mio $ am 31.03.2024
Profil
He Liang Fu is currently the Chairman at Jiangsu Aidea Pharmaceutical Co., Ltd.
He previously held the position of President at Techpool Bio-Pharma Co., Ltd.
and was a Professor at Sun Yat-Sen University.
He obtained his undergraduate degree from Nanjing University in 1989.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.08.2022 | 721 283 ( 0,33% ) | 2 Mio $ | 31.03.2024 | |
| 29.12.2022 | 1 167 600 ( 0,23% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von He Liang Fu
| Unternehmen | Position | Beginn |
|---|---|---|
| JIANGSU AIDEA PHARMACEUTICAL CO., LTD. | Chairman | 01.01.2014 |
Ehemalige bekannte Positionen von He Liang Fu
| Unternehmen | Position | Ende |
|---|---|---|
| Sun Yat-Sen University | Corporate Officer/Principal | - |
Techpool Bio-Pharma Co., Ltd.
 Techpool Bio-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Techpool Bio-Pharma Co., Ltd. researches, develops, manufactures, and markets bio-pharmaceutical products. Its products include Techpool Roan, Kailikang, Bondronat and Roxin. The firm specializes in the sales, research and development, and production of biopharmaceuticals in critical care. The company was founded in 1993 and is headquartered in Guangzhou, China. | President | - |
Ausbildung von He Liang Fu
| Nanjing University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| JIANGSU AIDEA PHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Techpool Bio-Pharma Co., Ltd.
Techpool Bio-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Techpool Bio-Pharma Co., Ltd. researches, develops, manufactures, and markets bio-pharmaceutical products. Its products include Techpool Roan, Kailikang, Bondronat and Roxin. The firm specializes in the sales, research and development, and production of biopharmaceuticals in critical care. The company was founded in 1993 and is headquartered in Guangzhou, China. | Health Technology |
